Cargando…
Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations
Bupropion, a Food and Drug Administration–approved antidepressant and smoking cessation aid, blocks dopamine and norepinephrine reuptake transporters and noncompetitively inhibits nicotinic acetylcholine and serotonin (5-HT) type 3A receptors (5-HT(3A)Rs). 5-HT(3) receptors are pentameric ligand-gat...
Autores principales: | Stuebler, Antonia G., Jansen, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978693/ https://www.ncbi.nlm.nih.gov/pubmed/31871303 http://dx.doi.org/10.1124/mol.119.118349 |
Ejemplares similares
-
Mobility of Lower MA-Helices for Ion Conduction through Lateral Portals in 5-HT(3A) Receptors
por: Stuebler, Antonia G., et al.
Publicado: (2020) -
Heteromeric TRP Channels in Lung Inflammation
por: Zergane, Meryam, et al.
Publicado: (2021) -
Modeling the kinetics of heteromeric potassium channels
por: McGahan, Kees, et al.
Publicado: (2022) -
Identification of a binding site for bupropion in Gloeobacter violaceus ligand-gated ion channel
por: Pirayesh, Elham, et al.
Publicado: (2023) -
Triple arginines as molecular determinants for pentameric assembly of the intracellular domain of 5-HT(3A) receptors
por: Pandhare, Akash, et al.
Publicado: (2019)